E I D-Parry (India) Ltd
NSE:EIDPARRY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
E I D-Parry (India) Ltd
Accounts Receivables
E I D-Parry (India) Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E I D-Parry (India) Ltd
NSE:EIDPARRY
|
Accounts Receivables
₹26.6B
|
CAGR 3-Years
29%
|
CAGR 5-Years
14%
|
CAGR 10-Years
2%
|
|
|
UPL Ltd
NSE:UPL
|
Accounts Receivables
₹164.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Fertilisers And Chemicals Travancore Ltd
NSE:FACT
|
Accounts Receivables
₹5.6B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Sumitomo Chemical India Ltd
NSE:SUMICHEM
|
Accounts Receivables
₹9B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
PI Industries Ltd
NSE:PIIND
|
Accounts Receivables
₹24.9B
|
CAGR 3-Years
18%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Coromandel International Ltd
NSE:COROMANDEL
|
Accounts Receivables
₹21.7B
|
CAGR 3-Years
38%
|
CAGR 5-Years
14%
|
CAGR 10-Years
2%
|
|
E I D-Parry (India) Ltd
Glance View
In the bustling world of agribusiness, E I D-Parry (India) Ltd. emerges as a formidable player deeply rooted in the agricultural heartland of India. Founded in 1788, the company has evolved over two centuries to become a significant name in the sugar and nutraceutical arenas. At the core of its operations lies the sugar production segment, which remains a substantial contributor to its revenue stream. Encompassing sugarcane cultivation, processing, and refined sugar production, E I D-Parry leverages extensive expertise and technological advancements to maintain efficiency. By investing in integrated factories, which include state-of-the-art distilleries and cogeneration plants, the company optimizes its byproducts, efficiently producing ethanol and generating power for the grid. This approach not only maximizes profit margins but also underscores a commitment to sustainability. Beyond the traditional sugar business, E I D-Parry takes strides into the growing nutraceutical market, sensing the opportunity to capitalize on the increasing global wellness trend. Through its subsidiary, Parry Nutraceuticals, the company delves into the extraction and commercialization of high-value health supplements, such as spirulina and microalgae. This diversification is not only a hedge against the volatile sugar market but also a step towards leveraging its expertise in fermentation technology. By strategically expanding its portfolio and tapping into value-added products, E I D-Parry crafts a multifaceted business model that stays resilient amid cyclical agricultural dynamics, positioning itself as a forward-thinking entity in both local and international markets.
See Also
What is E I D-Parry (India) Ltd's Accounts Receivables?
Accounts Receivables
26.6B
INR
Based on the financial report for Dec 31, 2025, E I D-Parry (India) Ltd's Accounts Receivables amounts to 26.6B INR.
What is E I D-Parry (India) Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
2%
Over the last year, the Accounts Receivables growth was 17%. The average annual Accounts Receivables growth rates for E I D-Parry (India) Ltd have been 29% over the past three years , 14% over the past five years , and 2% over the past ten years .